269 related articles for article (PubMed ID: 24684846)
1. Pemetrexed and gemcitabine as combination therapy for the treatment of Group3 medulloblastoma.
Morfouace M; Shelat A; Jacus M; Freeman BB; Turner D; Robinson S; Zindy F; Wang YD; Finkelstein D; Ayrault O; Bihannic L; Puget S; Li XN; Olson JM; Robinson GW; Guy RK; Stewart CF; Gajjar A; Roussel MF
Cancer Cell; 2014 Apr; 25(4):516-29. PubMed ID: 24684846
[TBL] [Abstract][Full Text] [Related]
2. The role of pemetrexed combined with gemcitabine for non-small-cell lung cancer.
Ngeow J; Toh CK
Curr Drug Targets; 2010 Jan; 11(1):61-6. PubMed ID: 19839926
[TBL] [Abstract][Full Text] [Related]
3. In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients.
Mey V; Giovannetti E; De Braud F; Nannizzi S; Curigliano G; Verweij F; De Cobelli O; Pece S; Del Tacca M; Danesi R
Br J Cancer; 2006 Aug; 95(3):289-97. PubMed ID: 16868547
[TBL] [Abstract][Full Text] [Related]
4. Novel combinations using pemetrexed in malignant mesothelioma.
Gadgeel SM; Pass HI
Clin Lung Cancer; 2004 Apr; 5 Suppl 2():S61-6. PubMed ID: 15117427
[TBL] [Abstract][Full Text] [Related]
5. The pemetrexed/gemcitabine combination in pancreatic cancer.
Kindler HL
Cancer; 2002 Aug; 95(4 Suppl):928-32. PubMed ID: 12209673
[TBL] [Abstract][Full Text] [Related]
6. Preclinical and clinical studies with combinations of pemetrexed and gemcitabine.
Adjei AA
Semin Oncol; 2002 Dec; 29(6 Suppl 18):30-4. PubMed ID: 12571808
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine and pemetrexed combination: the key role of the sequence of drugs administration.
De Pas TM; Toffalorio F; Catania C; Noberasco C; Spitaleri G; Spaggiari L; De Braud F
Ann Oncol; 2009 Oct; 20(10):1747-8. PubMed ID: 19690055
[No Abstract] [Full Text] [Related]
8. Clinical studies of pemetrexed and gemcitabine combinations.
Adjei AA
Ann Oncol; 2006 May; 17 Suppl 5():v29-32. PubMed ID: 16807459
[TBL] [Abstract][Full Text] [Related]
9. Pemetrexed in pancreatic cancer.
Kindler HL
Semin Oncol; 2002 Dec; 29(6 Suppl 18):49-53. PubMed ID: 12571811
[TBL] [Abstract][Full Text] [Related]
10. Review of the pemetrexed and gemcitabine combination in patients with advanced-stage non-small cell lung cancer.
Monnerat C; Le Chevalier T
Ann Oncol; 2006 May; 17 Suppl 5():v86-90. PubMed ID: 16807472
[TBL] [Abstract][Full Text] [Related]
11. Pemetrexed in pancreatic cancer.
Seitz JF; Dahan L; Ries P
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):43-7. PubMed ID: 15655936
[TBL] [Abstract][Full Text] [Related]
12. Gemcitabine and pemetrexed disodium combinations in vitro and in vivo.
Adjei AA
Lung Cancer; 2001 Dec; 34 Suppl 4():S103-5. PubMed ID: 11742712
[TBL] [Abstract][Full Text] [Related]
13. [Gemcitabine and pemetrexed in genito-urinary tumors treatment].
Fléchon A
Bull Cancer; 2007; 94 Spec No Actualites():S116-21. PubMed ID: 17845980
[TBL] [Abstract][Full Text] [Related]
14. Targeting MYC-driven replication stress in medulloblastoma with AZD1775 and gemcitabine.
Moreira DC; Venkataraman S; Subramanian A; Desisto J; Balakrishnan I; Prince E; Pierce A; Griesinger A; Green A; Eberhardt CG; Foreman NK; Vibhakar R
J Neurooncol; 2020 May; 147(3):531-545. PubMed ID: 32180106
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine and Pemetrexed disodium in treating breast cancer.
Adjei AA
Oncology (Williston Park); 2001 Feb; 15(2 Suppl 3):34-7. PubMed ID: 11252887
[TBL] [Abstract][Full Text] [Related]
16. A phase II trial of pemetrexed plus gemcitabine in locally advanced and/or metastatic transitional cell carcinoma of the urothelium.
von der Maase H; Lehmann J; Gravis G; Joensuu H; Geertsen PF; Gough J; Chen G; Kania M
Ann Oncol; 2006 Oct; 17(10):1533-8. PubMed ID: 16873433
[TBL] [Abstract][Full Text] [Related]
17. A phase 2 study of pemetrexed plus gemcitabine every 2 weeks for patients with recurrent or metastatic head and neck squamous cell cancer.
Fury MG; Haque S; Stambuk H; Shen R; Carlson D; Pfister D
Cancer; 2011 Feb; 117(4):795-801. PubMed ID: 20922785
[TBL] [Abstract][Full Text] [Related]
18. Pemetrexed in transitional cell carcinoma of the urothelium.
von der Maase H
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):48-50. PubMed ID: 15655937
[TBL] [Abstract][Full Text] [Related]
19. Optimizing pemetrexed-gemcitabine combination in patients with advanced non-small cell lung cancer: a pharmacogenetic approach.
De Pas TM; Toffalorio F; Giovannetti E; Radice D; Russo F; Angeli I; Calamai G; Spitaleri G; Catania C; Noberasco C; Milani A; Pelosi G; Danesi R; De Braud F
J Thorac Oncol; 2011 Apr; 6(4):768-73. PubMed ID: 21336182
[TBL] [Abstract][Full Text] [Related]
20. Gemcitabine, pemetrexed, and novel agents in the treatment of thoracic cancer. Selected presentations from the 10th World Congress on Lung Cancer. Vancouver, Canada.
Oncology (Williston Park); 2004 Jul; 18(8 Suppl 5):5-71. PubMed ID: 15675032
[No Abstract] [Full Text] [Related]
[Next] [New Search]
